Methods and compositions for diagnosing and treating disorders involving angiogenesis

Details for Australian Patent Application No. 2004245761 (hide)

Owner Pfizer Products Inc.

Inventors Cai, Jenny Hong; Tong, Xiao

Agent Allens Arthur Robinson

Pub. Number AU-A-2004245761

PCT Pub. Number WO2004/108916

Priority 60/476,430 06.06.03 US

Filing date 24 May 2004

Wipo publication date 16 December 2004

International Classifications

C12N 009/68 Enzymes, e.g. ligases (6.) - Plasmin, i.e. fibrinolysin

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/108916 Priority application(s): WO2004/108916

21 June 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245762-Methods for predicting drug efficacy in patients afflicted with hypertension

2004245757-Drive engagement apparatus